After leaving the issue of thyroid cancer epidemics in Korea out of the discussion \[[@B1]\], it is clear that thyroid nodules are common worldwide, ranging from 5% to 7% of the adult population. Furthermore, the cost-of-illness of thyroid disease is relatively great in an economically active age group, and demonstrates a very rapid growth rate in Korea, which is facing an economic burden regarding the diagnosis and treatment of thyroid diseases, especially involving thyroid nodules \[[@B2]\]. The vast majority of cases are benign, and most cases of thyroid cancer are curable by surgery if detected early. Fine-needle aspiration (FNA) of the thyroid plays a pivotal role in distinguishing benign and malignant lesions, triaging patients who need the appropriate surgery and reducing the rate of unnecessary thyroid surgery for patients with benign lesions. Up to 80% of thyroid nodules are clearly classified as either benign or malignant; however, the remaining 20% to 30% of them have equivocal findings including indeterminate, atypia or suspicious, usually due to vagueness of the optical images. These nodules usually require re-aspiration or surgery for a definite diagnosis, which increases the inconvenience and cost. The current guidelines recommend repeat FNA for patients with a diagnosis of \"atypia of undetermined significance\" and lobectomy with or without intraoperative pathology consultation for those with a suspicious diagnosis.

In addition to such a degree of uncertainty with regard to FNA, operators\' experience should be taken into consideration when diagnosing thyroid cancer. According to a recent paper in *Endocrinology and Metabolism*, Son et al. \[[@B3]\] reported that a non-experienced group had a substantially higher false-negative rate than an experienced group, and the sensitivity of the FNA test also tended to be lower in the non-experienced group. There are certainly interpersonal and inter-institutional differences in the diagnostic accuracy of thyroid FNA; thus, an intensive training program and a high standard of qualified operators are required.

Meanwhile, in order to improve the diagnostic accuracy of thyroid FNA, new approaches including molecular analysis for somatic genetic alterations such as BRAF and RAS point mutations and RET/PTC and PAX8/PPARγ rearrangements have been developed for either clinical-based or lab-based use.

There is no doubt that FNA should be performed by well-trained operators; molecular analysis using thyroid aspirates enables the identification of patients who need to proceed to surgery, and might guide the extent of surgery necessary. Moreover, a gene expression classifier enables the identification of patients who do not need surgery and can be safely followed.
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